https://www.selleckchem.com/pr....oducts/Clofarabine.h
es 8 and 9. The accepted treatment for idiopathic sudden sensorineural hearing loss (ISSNHL) consists of oral or intratympanic steroids. The time from onset to treatment is considered as an important prognostic factor, although there is no clear cutoff point when treatment is no longer beneficial. This study aimed to assess the efficacy of treatment with oral or intratympanic steroids and carbogen, in patients presenting 21 days or later after the onset of hearing loss. A total of 895 patients with ISSNHL was seen in our center betw
Curtir
Comentario
Compartilhar
